| escitalopram / Generic mfg. |
| Recruiting | 4 | 2688 | | | Brain Resource, Brain Resource | Major Depressive Disorder (MDD) | | | | |
| Completed | 4 | 50 | | | The University of Sydney, Australian Research Council | Depression, Anxiety | | | | |
NCT00222820: Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study |
|
|
| Completed | 4 | 35 | US | escitalopram, Interpersonal Psychotherapy | University of Pittsburgh, Mental Health Intervention Research Center (MHIRC) | Major Depression | | 09/04 | | |
NCT00565422: Efficacy of Escitalopram in the Treatment of Internet Addiction |
|
|
| Completed | 4 | 31 | US | Escitalopram, Lexapro | Icahn School of Medicine at Mount Sinai, Forest Laboratories | Internet Addiction | | 10/04 | | |
NCT00423969: Galantamine Augmentation of Escitalopram for Treatment of Depression |
|
|
| Terminated | 4 | 20 | US | Galantamine, Escitalopram | Indiana University School of Medicine | Depression | | 09/05 | | |
NCT00115011: Escitalopram for the Treatment of Self-Injurious Skin Picking |
|
|
| Completed | 4 | 30 | US | Escitalopram | Massachusetts General Hospital, Forest Laboratories | Impulse Control Disorders | | 11/05 | | |
2005-001991-11: Effekte von Escitalopram auf Aufmerksamkeit und kognitive Funktionen bei gesunden Probanden |
|
|
| Not yet recruiting | 4 | 100 | Europe | escitalopram, Tablet, Cipralex 10mg | University of Aachen | 50 gesunde Probanden erhalten randomisiert, doppelt blind einmalig 10 mg Escitalopram oder Placebo im "cross over"-Design.50 weitere gesunde Probanden erhalten randomisiert, doppelt blind sieben Tage lang täglich 10 mg Escitalopram oder Placebo im "cross over"-Design.Nach der Medikamenteneinnahme erfolgt eine testpsychologische Untersuchung und eine fMRI-Untersuchung. | | | | |
NCT00368862: Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. |
|
|
| Completed | 4 | 80 | Europe | Ebixa (memantine hydrochloride), Cipralex (escitalopram) | Finnish Institute for Health and Welfare, Finnish Foundation for Alcohol Studies | Alcoholism, Depression | | 06/06 | | |
NCT00296712: Are Two Antidepressants a Good Initial Treatment for Depression? |
|
|
| Completed | 4 | 55 | US | escitalopram + bupropion, escitalopram = Lexapro, bupropion = Wellbutrin | New York State Psychiatric Institute | Major Depression, Dysthymia, Depression NOS | 07/06 | 07/06 | | |
NCT00157547: Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression |
|
|
| Completed | 4 | 95 | US | Selective serotonin reuptake inhibitors (SSRI), fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, escitalopram, venlafaxine | Massachusetts General Hospital, Medtronic - MITG | Major Depressive Disorder | 08/06 | 08/06 | | |
NCT00229333: Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia |
|
|
| Unknown status | 4 | 40 | RoW | Escitalopram | Sheba Medical Center, H. Lundbeck A/S | Depressive Syndrome | | | | |
| Completed | 4 | 294 | Canada, Europe | Escitalopram, Cipralex, Lexapro, Duloxetine, Cymbalta | H. Lundbeck A/S | Major Depressive Disorder | 09/06 | 11/06 | | |
2006-002880-19: Comparación de dos estrategias de intervención para el tratamiento de los trastornos depresivos en pacientes oncológicos |
|
|
| Ongoing | 4 | 200 | Europe | cipralex, Capsule*, Cipralex | Servicio de psiquiatria. Hospital Universitario La Paz | Major depressive Disorder, one episode or several episodes.ICD: 296.2x, 296.3x | | | | |
NCT00151294: The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis |
|
|
| Terminated | 4 | 20 | US | escitalopram oxalate antidepressant | Weill Medical College of Cornell University, Forest Laboratories | Depression, Multiple Sclerosis | | 10/06 | | |
NCT00234312: Medications for the Treatment of Dysthymic Disorder and Double Depression |
|
|
| Completed | 4 | 40 | US | escitalopram and sertraline | Oregon Health and Science University, Forest Laboratories | Depression, Dysthymia | 10/06 | 10/06 | | |
| Completed | 4 | 30 | US | Escitalopram, Lexapro, Placebo | University of California, San Francisco | Depression | 12/06 | 11/08 | | |
NCT00260624: Escitalopram Treatment of Patients With Agitated Dementia |
|
|
| Completed | 4 | 20 | US | Escitalopram (Lexapro) | University of Rochester, Forest Laboratories | Alzheimer's Disease, Psychomotor Agitation | 12/06 | 12/06 | | |
NCT00116532: Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) |
|
|
| Completed | 4 | 30 | US | Escitalopram | Massachusetts General Hospital, Forest Laboratories | Obsessive Compulsive Disorder | | 02/07 | | |
NCT00296790: Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro) |
|
|
| Completed | 4 | 372 | US | zolpidem tartrate | Sanofi | Insomnia | | 02/07 | | |
NCT00442481: Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder |
|
|
| Unknown status | 4 | 25 | RoW | Escitalopram, A baseline overnight polysomnography (oPSG) | Sheba Medical Center, Lundbeck Israel | Major Depressive Disorder | | | | |
| Completed | 4 | 50 | Europe | escitalopram | Odense University Hospital, Aarhus University Hospital, H. Lundbeck A/S | Pain, Polyneuropathies | | 04/07 | | |
NCT00296777: Treatment of Depression Following Multiple Brain Tests |
|
|
| Completed | 4 | 28 | US | Escitalopram, Lexapro, Bupropion, Wellbutrin, Imipramine, Tofranil, Pressamine | New York State Psychiatric Institute | Major Depression, Dysthymia | 05/07 | 12/07 | | |
NCT00375843: Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication |
|
|
| Completed | 4 | 118 | US | Escitalopram, Lexapro, Sertraline, Zoloft | National Institute of Mental Health (NIMH) | Depression | 06/07 | 03/08 | | |
NCT00296179: Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro |
|
|
| Completed | 4 | 372 | US | zolpidem tartrate | Sanofi | Insomnia | 06/07 | | | |
NCT00231335: Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia |
|
|
| Completed | 4 | 30 | US | escitalopram | Emory University, Forest Laboratories | Schizophrenia, Schizoaffective Disorder | | 07/07 | | |
NCT00456430: Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response |
|
|
| Completed | 4 | 80 | US | Escitalopram, lexapro | Indiana University School of Medicine | Depression | 08/07 | 08/07 | | |
NCT00767871: Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder |
|
|
| Completed | 4 | 46 | RoW | Lexapro | Samsung Medical Center, H. Lundbeck A/S | Panic Disorder | 08/07 | 12/08 | | |
| Completed | 4 | 290 | US, Europe | Escitalopram, Interpersonal Psychotherapy, Escitalopram plus IPT | University of Pittsburgh, National Institute of Mental Health (NIMH) | Depression | 10/07 | 10/07 | | |
NCT00384436: Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients |
|
|
| Completed | 4 | 580 | US | escitalopram | Forest Laboratories | Major Depressive Disorder | 10/07 | | | |
| Completed | 4 | 16 | Europe | Escitalopram | University of Southern Denmark, H. Lundbeck A/S | Healthy | 10/07 | 10/07 | | |
NCT00105586: Drug Therapy for Generalized Anxiety Disorder Among the Elderly |
|
|
| Completed | 4 | 177 | US | Escitalopram, Lexapro | University of Pittsburgh, National Institute of Mental Health (NIMH) | Anxiety Disorders, Generalized Anxiety Disorder | 01/08 | 04/08 | | |
| Terminated | 4 | 189 | Europe | escitalopram | Psychiatric Hospital, Hillerod, Psychogeriatric Unit, CU Hospital, Frederiksberg, Amager Hospital, Psychiatric Center Ballerup, Geriatric Department,Korsør, Vestsjælland | Depression | | 01/08 | | |
| Completed | 4 | 135 | Europe | escitalopram, Cipralex, bupropion, Wellbutrin | University of Tartu | Major Depression | 01/08 | 01/08 | | |
NCT00177216: Characteristics of Sleep Patterns in Young Adults With and Without Insomnia |
|
|
| Completed | 4 | 69 | US | Zolpidem, Ambien, Escitalopram, Celexa, Placebo, Placebo control | University of Pittsburgh, National Institute of Mental Health (NIMH) | Sleep Disorders | 05/08 | 05/08 | | |
NCT00209170: Depression-Diabetes Mechanisms: Urban African Americans |
|
|
| Completed | 4 | 20 | US | Beating the Blues, Escitalopram, Lexapro, Placebo | Emory University, National Institute of Mental Health (NIMH) | Diabetes, Depression | 05/08 | 05/08 | | |
NCT00219349: Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) |
|
|
| Completed | 4 | 25 | US | Cognitive Behavioral Therapy, escitalopram, lexapro | New York State Psychiatric Institute, Forest Laboratories | Generalized Anxiety Disorder | 07/08 | 07/08 | | |
| Completed | 4 | 15 | Europe | escitalopram and tramadol, Lexapro, Ultram, placebo, placebo and tramadol | University of Southern Denmark, H. Lundbeck A/S | Healthy | 08/08 | 08/08 | | |
NCT00456937: Escitalopram in Schizophrenia in OCD- Open Label Study |
|
|
| Completed | 4 | 15 | RoW | Escitalopram | BeerYaakov Mental Health Center, Lundbeck Israel | Schizophrenia | 09/08 | 09/08 | | |
NCT00220701: Escitalopram in the Treatment of Dysthymic Disorder, Double Blind |
|
|
| Completed | 4 | 36 | US | Lexapro (escitalopram), lexapro, escitalopram, s-citalopram, d-citalopram | St. Luke's-Roosevelt Hospital Center, Forest Laboratories | Dysthymic Disorder | 11/08 | 01/09 | | |
NCT00140257: DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome |
|
|
| Unknown status | 4 | 240 | Europe | Escitalopram | Bispebjerg Hospital, H. Lundbeck A/S, Danish Heart Foundation, The Danish Medical Research Council | Depression | 12/08 | | | |
| Completed | 4 | 40 | US | Escitalopram, Lexapro, Desipramine, Norpramin | Emory University, National Heart, Lung, and Blood Institute (NHLBI) | Major Depressive Disorder | 01/09 | 01/09 | | |
| Terminated | 4 | 150 | Europe | escitalopram | Nordfjord Psychiatric Centre, H. Lundbeck A/S | Bipolar Disorder | 03/09 | 03/09 | | |
NCT00813735: Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder |
|
|
| Completed | 4 | 60 | US | Eszopiclone, Escitalopram 10mg or 20mg daily in the AM, Placebo, Escitalopram | Lehigh Center for Clinical Research, Sunovion | Insomnia | 03/09 | 04/09 | | |
NCT01797380: A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women |
|
|
| Terminated | 4 | 5 | US | Placebo, Escitalopram | Duke University | Depression, HIV | 04/09 | 04/09 | | |
NCT00183677: Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram |
|
|
| Completed | 4 | 97 | US | Escitalopram, Lexapro | Massachusetts General Hospital | Depression | 06/09 | 06/09 | | |
NCT00200902: Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression |
|
|
| Completed | 4 | 88 | US | Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro), Placebo, Interpersonal Clinical Interaction (ICI) | University of California, Los Angeles, National Center for Complementary and Integrative Health (NCCIH), Eli Lilly and Company, Wyeth is now a wholly owned subsidiary of Pfizer | Depression | 06/09 | 06/09 | | |
| Unknown status | 4 | 42 | Europe | escitalopram, reboxetine, Reboxetine, No intervention | Hospital Universitari Vall d'Hebron Research Institute | Major Depression, Pain, Abdominal Pain | 06/09 | 04/11 | | |
NCT00386841: Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression |
|
|
| Completed | 4 | 80 | Europe | Escitalopram, cipralex, Placebo | University of Copenhagen | Healthy | 06/09 | 06/09 | | |
| Unknown status | 4 | 30 | RoW | Escitalopram | Sheba Medical Center | Major Depression, Diabetes Mellitus | 06/09 | 10/09 | | |
NCT00902421: Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients |
|
|
| Completed | 4 | 40 | RoW | Selective serotonin reuptake inhibitors, Lexapro®, Antimuscarinics | Samsung Medical Center | Overactive Bladder | 07/09 | 07/09 | | |
NCT00177294: Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression |
|
|
| Completed | 4 | 319 | US | Escitalopram, Lexapro, Interpersonal Psychotherapy, IPT, Clinical Monitoring | University of Pittsburgh, National Institute of Mental Health (NIMH) | Depression | 08/09 | 08/09 | | |
NCT00177671: Antidepressant Medication Plus Donepezil for Treating Late-life Depression |
|
|
| Completed | 4 | 220 | US | Escitalopram, Lexapro, Donepezil, aricept, Venlafaxine, effexor XR, Placebo, Duloxetine, cymbalta | University of Pittsburgh, National Institute of Mental Health (NIMH) | Depression, Dementia | 09/09 | 09/09 | | |
NCT00464711: Brain GABA Levels and Treatment Response in Major Depressive Disorder |
|
|
| Completed | 4 | 40 | US | Escitalopram, Lexapro | Massachusetts General Hospital, Mclean Hospital | Major Depressive Disorder | 09/09 | 09/09 | | |
| Completed | 4 | 665 | US | SSRI + placebo, escitalopram, placebo, Escitalopram + Bupropion SR, bupropion-SR, Venlafaxine XR + Mirtazapine, venlafaxine-XR, mirtazapine | National Institute of Mental Health (NIMH) | Major Depressive Disorder | 09/09 | 09/09 | | |
NCT00523705: Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study |
|
|
| Terminated | 4 | 11 | US | escitalopram, Lexapro, placebo | University of Pennsylvania, Forest Laboratories | PMS | 10/09 | 10/09 | | |
NCT00628914: Brain Mechanisms and Targeting Insomnia in Major Depression |
|
|
| Unknown status | 4 | 60 | US | escitalopram and eszopiclone, Lexapro, Lunesta, Escitalopram, eszopiclone, and placebo, Escitalopram | University of California, Los Angeles | Major Depressive Disorder, Insomnia | 11/09 | 02/10 | | |
NCT00145132: Beta-CIT-SPECT and Neurophysiology in Depression |
|
|
| Completed | 4 | 30 | Europe | β-CIT-SPECT, Neurophysiology | Ludwig-Maximilians - University of Munich, H. Lundbeck A/S | Depression | 12/09 | 12/09 | | |
NCT00595699: Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy |
|
|
| Completed | 4 | 8 | US | escitalopram, Lexapro, placebo | Conrad, Erich J., M.D., Forest Laboratories | Major Depression, Temporal Lobe Epilepsy | 12/09 | 12/09 | | |
| Completed | 4 | 60 | Europe | escitalopram | Community Pharmacology Services Ltd | Major Depressive Disorder | 12/09 | 12/09 | | |
NCT00902226: Escitalopram in Patients With Social Anxiety Disorder |
|
|
| Completed | 4 | 30 | RoW | Escitalopram, Cipralex, Lexapro | H. Lundbeck A/S | Social Anxiety Disorder | 12/09 | 03/10 | | |
NCT00902564: Escitalopram in Patients With Generalized Anxiety Disorder |
|
|
| Completed | 4 | 30 | RoW | Escitalopram, Cipralex, Lexapro | H. Lundbeck A/S | Generalized Anxiety Disorder | 12/09 | 03/10 | | |
| Completed | 4 | 840 | Europe, RoW | Duloxetine Hydrochloride, Cymbalta, LY248686, Escitalopram, Lexapro, Cipralex | Eli Lilly and Company | Major Depressive Disorder | 02/10 | 03/10 | | |
NCT00621946: Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder |
|
|
| Completed | 4 | 26 | US | Placebo, Placebo Matching Escitalopram, Escitalopram | University of Texas Southwestern Medical Center, Forest Laboratories | Severe Asthma, Moderate or Severe Major Depressive Disorder | 03/10 | 03/10 | | |
EscBPSD, NCT01119638: Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone |
|
|
| Completed | 4 | 40 | RoW | Escitalopram, Cipralex, Risperidone, Risperdal | Abarbanel Mental Health Center | Agitation, Psychosis, Alzheimer's Disease | 04/10 | 05/10 | | |
NCT00918684: Aging Brain Changes, Executive Dysfunction and Depression |
|
|
| Completed | 4 | 116 | US | Escitalopram, Lexapro | Weill Medical College of Cornell University, National Institute of Mental Health (NIMH), Forest Laboratories | Depression | 05/10 | 05/10 | | |
NCT00452543: Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism |
|
|
| Completed | 4 | 23 | US | acamprosate, Campral, escitalopram, Lexapro, Medical management, Campral and Lexapro, Placebo | Massachusetts General Hospital, National Alliance for Research on Schizophrenia and Depression | Major Depressive Disorder, Alcohol Abuse, Alcohol Dependence | 05/10 | 05/10 | | |
NCT00352885: Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment |
|
|
| Completed | 4 | 20 | US | Escitalopram, Lexapro, Placebo, Sugar pill, IL-2 | Emory University, National Institute of Mental Health (NIMH) | Depression | 05/10 | 05/10 | | |
NCT00708396: Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study |
|
|
| Unknown status | 4 | 20 | RoW | Escitalopram | BeerYaakov Mental Health Center | OCD, Schizophrenia | 07/10 | 07/10 | | |
NCT00967408: Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke Patients |
|
|
| Unknown status | 4 | 200 | Europe | Escitalopram, ATC N06AB10, Placebo, Rehabilitative treatment | Azienda Ospedaliero Universitaria Maggiore della Carita | Stroke | 07/10 | 10/11 | | |
2009-016953-16: Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit |
|
|
| Ongoing | 4 | 120 | Europe | Cipralex, Solvex, Remergil, Elontril, Valdoxan, Tablet, Cipralex, Solvex, Remergil, Elontril, Valdoxan | Inn-Salzach-Klinikum gGmbH | Spectrum of depressive diseases, ICD-10: F32.x, F33.x | | | | |
NCT00708240: Treatment Youth With Obsessive-Compulsive Disorder |
|
|
| Unknown status | 4 | 40 | Canada | Escitalopram, Cipralex | University of Ottawa, H. Lundbeck A/S | Obsessive Compulsive Disorder | 08/10 | 12/10 | | |
| Terminated | 4 | 3 | US | escitalopram, Lexapro (escitalopram), placebo | University of Washington, National Institutes of Health (NIH), Forest Laboratories | Chronic Sinusitis, Facial Pain Disorder, Depression | 08/10 | 12/12 | | |
| Completed | 4 | 149 | Europe | Risperidone, ATC code N05AX 08, Escitalopram, ATC code N06AB 10, Citalopram, ATC code N06AB 04, Sertraline, ATC code N06AB 06, Paroxetine, ATC code N06AB 05 | Sykehuset Innlandet HF, Ullevaal University Hospital, Eikertun Nursing Home, University of Bergen, Innlandet Hospital Trust, Sanderud, Innlandet Hospital Trust, Reinsvoll, Diakonhjemmet Hospital, Sykehuset Telemark, The Nordmøre and Romsdal Hospital Trust, Songdalstunet Nursing Home, Sykehuset Buskerud HF, Kroken Nursing Home, Tromsø, Kløveråsen, Bodø, Bjørgene Omsorgssenter, Haugesund, Alesund Hospital | Dementia | 12/10 | 12/10 | | |
| Completed | 4 | 483 | Canada, RoW | Duloxetine, Cymbalta, LY248686, Escitalopram | Eli Lilly and Company, Boehringer Ingelheim | Major Depressive Disorder | 12/10 | 12/10 | | |
ChiCTR-TNRC-10001112: The study on clinical and biological characters of bipolar depression and the treatment scheme optimizing |
|
|
| Completed | 4 | 640 | | Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride | Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health; Guangzhou first people's hospital, The Tackling Key Problems of Guangzhou Scientific and Technological Project | bipolar depressive disorder | | | | |
NCT00826111: The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia |
|
|
| Completed | 4 | 19 | US | Eszopiclone, Lunesta, Placebo | Steward St. Elizabeth's Medical Center of Boston, Inc., Sunovion | Depression, Anxiety, Insomnia | 01/11 | 07/11 | | |
NCT00723060: Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder |
|
|
| Completed | 4 | 176 | RoW | escitalopram | Seoul National University Hospital | Obsessive Compulsive Disorder | 01/11 | 01/11 | | |
NCT01541475: Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder |
|
|
| Completed | 4 | 60 | RoW | Bupropion, Escitalopram, Escitalopram | Ewha Womans University, GlaxoSmithKline | Major Depressive Disorder | 01/11 | 01/11 | | |
TANESN, NCT01078870: Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype |
|
|
| Unknown status | 4 | 75 | RoW | Lexapro, Cymbalta, Placebo | National Taiwan University Hospital | Schizophrenia | 01/11 | 01/11 | | |
NCT00243477: MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting |
|
|
| Completed | 4 | 368 | Europe | Escitalopram, Seroplex | Hopital Jean Minjoz, H. Lundbeck A/S | Coronary Artery Disease | 02/11 | 02/12 | | |
NCT00824044: Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression |
|
|
| Completed | 4 | 39 | US | Cognitive Behavioral Therapy (CBT), Escitalopram, Lexapro | Massachusetts General Hospital, National Alliance for Research on Schizophrenia and Depression | Major Depressive Disorder | 03/11 | 03/11 | | |
NCT01101685: Neural Responses and Dysphoria: Modulation by a Pharmacological Probe |
|
|
| Completed | 4 | 160 | Europe | Escitalopram, Placebo | University of Oxford, P1vital Limited, University of Manchester, Institute of Psychiatry, London | Dysphoria | 03/11 | 03/11 | | |
2010-023007-10: A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response |
|
|
| Ongoing | 4 | 48 | Europe | Cipralex, Capsule, Cipralex | Uppsala university | Men and women diagnosed with DSM-IV social phobia (social anxiety disorder) | | | | |
NCT00825825: Brain Effects of Escitalopram and Citalopram Using fMRI |
|
|
| Completed | 4 | 27 | US | Escitalopram, Lexapro, Citalopram, Celexa, Placebo | Michael Henry, MD, Forest Laboratories | Antidepressant Activity in Healthy Volunteers | 04/11 | 04/11 | | |
| Completed | 4 | 7 | US | Escitalopram, Lexapro | Massachusetts General Hospital, Forest Laboratories | Postpartum Depression | 04/11 | 04/11 | | |
NCT00872027: Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit |
|
|
| Completed | 4 | 15 | US | Escitalopram, Lexapro, Placebo | University of Minnesota, National Institute of Mental Health (NIMH) | Depression | 04/11 | 07/11 | | |
Lexapro, NCT01814098: An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms |
|
|
| Completed | 4 | 318 | RoW | Escitalopram, Lexapro | Xian-Janssen Pharmaceutical Ltd. | Depressive Disorder, Major | 05/11 | 11/11 | | |
| Completed | 4 | 65 | US | Escitalopram | Massachusetts General Hospital, Forest Laboratories | Fear Conditioning | 06/11 | 06/11 | | |
| Terminated | 4 | 50 | | | Mood Research Foundation (WA), Mood Research Foundation (WA) | Chronic illness - patients who are generally unwell for an extended period. | | | | |
NCT00519428: Does Dual Therapy Hasten Antidepressant Response? |
|
|
| Completed | 4 | 245 | US, Canada | escitalopram, Lexapro, bupropion extra long (XL), Wellbutrin extra long (XL), escitalopram + bupropion, Wellbutrin | New York State Psychiatric Institute, University of Ottawa, National Institute of Mental Health (NIMH) | Major Depressive Disorder | 07/11 | 03/12 | | |
NCT00404755: Dichotic Listening as a Predictor of Medication Response in Depression |
|
|
| Completed | 4 | 17 | US | escitalopram, Lexapro., bupropion, Wellbutrin, imipramine, Tofranil | New York State Psychiatric Institute | Major Depressive Disorder, Dysthymia | 08/11 | 08/11 | | |
| Completed | 4 | 127 | US | Escitalopram, Lexapro, Placebo | Duke University, National Heart, Lung, and Blood Institute (NHLBI) | Myocardial Ischemia | 11/11 | 11/11 | | |
| Withdrawn | 4 | 0 | Europe | simultaneous EEG/fMRI, fMRI | Ludwig-Maximilians - University of Munich, H. Lundbeck A/S | Depression | 12/11 | 12/11 | | |
NCT01244724: Lexapro for Major Depression in Patients With Epilepsy |
|
|
| Terminated | 4 | 26 | US | Lexapro, Escitalopram | Weill Medical College of Cornell University, Forest Laboratories | Major Depression, Epilepsy | 12/11 | 03/12 | | |
ACTRN12613000256774: Escitalopram efficacy and tolerability in treatment resistant depression. an open study. |
|
|
| Completed | 4 | 417 | | | Lundbeck , Lundbeck | Major Depression | | | | |
NCT00693732: Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS) |
|
|
| Completed | 4 | 30 | RoW | Escitalopram treatment, Lexapro, Quantitative sensory testing | National University Hospital, Singapore, NMRC, Singapore | Irritable Bowel Syndrome | 01/12 | 01/12 | | |
NCT01814085: A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression |
|
|
| Completed | 4 | 225 | RoW | Escitalopram, Lexapro | Xian-Janssen Pharmaceutical Ltd. | Major Depressive Disorder | 02/12 | 03/12 | | |
NCT00917059: Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study) |
|
|
| Completed | 4 | 172 | US | Escitalopram, Lexapro, Bupropion XL, Wellbutrin XL | University of California, Los Angeles, National Institute of Mental Health (NIMH) | Depression | 05/12 | 05/12 | | |
PROTECT, NCT00536172: Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment |
|
|
| Completed | 4 | 160 | US | Escitalopram, Lexapro, Placebo, Sugar pill, Inactive substance | University of Nebraska, National Institute of Mental Health (NIMH) | Depression | 06/12 | 06/12 | | |
2011-005541-12: Efficacy of escitalopram treatment i acute stroke and the role of specific genotypes in stroke Effekekten af escitalopram-behandling ved akut slagtilfælde og arvemassens betydning for slagtilfælde |
|
|
| Terminated | 4 | 600 | Europe | Film-coated tablet, Cipralex | Grethe Andersen, Lundbeck Pharma | Stroke Iskæmisk apopleksi, Stroke Slagtilfælde, Diseases [C] - Nervous System Diseases [C10] | | | | |
